Safety, Effectiveness and Quality of Life of Trastuzumab Deruxtecan in Patients with HER2+ Breast Cancer
Clinical trial NCT05149014 · COMPLETED
Trial details
- NCT number
- NCT05149014
- Sponsor
- Daiichi Sankyo France
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-12-14
- Primary completion
- 2024-06-24
- Enrollment
- 306
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.